Modified vaccinia virus Ankara: history, value in basic research, and current perspectives for vaccine development
A Volz, G Sutter - Advances in virus research, 2017 - Elsevier
Abstract Safety tested Modified Vaccinia virus Ankara (MVA) is licensed as third-generation
vaccine against smallpox and serves as a potent vector system for development of new …
vaccine against smallpox and serves as a potent vector system for development of new …
The evolution of poxvirus vaccines
After Edward Jenner established human vaccination over 200 years ago, attenuated
poxviruses became key players to contain the deadliest virus of its own family: Variola virus …
poxviruses became key players to contain the deadliest virus of its own family: Variola virus …
Next generation vaccines and vectors: Designing downstream processes for recombinant protein‐based virus‐like particles
In recent years, the development of novel recombinant virus‐like particles (VLPs) has been
generating new perspectives for the prevention of untreated and arising infectious diseases …
generating new perspectives for the prevention of untreated and arising infectious diseases …
Recombinant modified vaccinia virus Ankara-based malaria vaccines
S Sebastian, SC Gilbert - Expert review of vaccines, 2016 - Taylor & Francis
A safe and effective malaria vaccine is a crucial part of the roadmap to malaria
elimination/eradication by the year 2050. Viral-vectored vaccines based on adenoviruses …
elimination/eradication by the year 2050. Viral-vectored vaccines based on adenoviruses …
[图书][B] Viral nanotechnology
Y Khudyakov, P Pumpens - 2015 - books.google.com
This book presents a review of a rapidly developing field of viral nanotechnology in the
context of immunology, virology, microbiology, chemistry, physics, and mathematical …
context of immunology, virology, microbiology, chemistry, physics, and mathematical …
Relevance of long-lived CD8+ T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination
JR Vasconcelos, MR Dominguez, AF Araújo… - Frontiers in …, 2012 - frontiersin.org
Owing to the importance of major histocompatibility complex class Ia-restricted CD8+ T cells
for host survival following viral, bacterial, fungal, or parasitic infection, it has become largely …
for host survival following viral, bacterial, fungal, or parasitic infection, it has become largely …
Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
W Akahata, R Ueno - US Patent 9,637,532, 2017 - Google Patents
Rodrigues M et al., Influenza and Vaccinia viruses expressing Malaria CD8+ T and B Cell
epitopes. Comparison of their immunogenicity and capacity to induce protective immunity, J …
epitopes. Comparison of their immunogenicity and capacity to induce protective immunity, J …
Vaccination Using Recombinants Influenza and Adenoviruses Encoding Amastigote Surface Protein-2 Are Highly Effective on Protection against Trypanosoma cruzi …
RPA Barbosa, BG Filho, LI Santos, PAS Junior… - PLoS …, 2013 - journals.plos.org
In the present study we evaluated the protection raised by immunization with recombinant
influenza viruses carrying sequences coding for polypeptides corresponding to medial and …
influenza viruses carrying sequences coding for polypeptides corresponding to medial and …
猪细小病毒病毒样颗粒疫苗研究进展
刘运超， 陈玉梅， 姬鹏超， 赵宝磊， 王聚财， 邓瑞广… - 河南农业科学, 2015 - hnnykx.org.cn
猪细小病毒(PPV) 感染可导致母猪繁殖障碍, 断奶仔猪多系统衰弱综合征和肠炎性腹泻等疾病,
给养猪业造成巨大的经济损失. 临床防控以接种疫苗为主, 常用的疫苗有弱毒疫苗和灭活疫苗 …
给养猪业造成巨大的经济损失. 临床防控以接种疫苗为主, 常用的疫苗有弱毒疫苗和灭活疫苗 …
Generation of porcine reproductive and respiratory syndrome (PRRS) virus-like-particles (VLPs) with different protein composition
MG Durán, S Costa, J Sarraseca, N de la Roja… - Journal of virological …, 2016 - Elsevier
The causative agent of Porcine Reproductive and Respiratory Syndrome (PRRS) is an
enveloped ssRNA (+) virus belonging to the Arteriviridae family. Gp5 and M proteins form …
enveloped ssRNA (+) virus belonging to the Arteriviridae family. Gp5 and M proteins form …